Committee for Medicinal Products for Human Use - PDFSEARCH.IO - Document Search Engine

Committee for Medicinal Products for Human Use
Results: 188

#	Item
151	European Medicines Agency Doc. Ref.: EMEA[removed] Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 05:13:55 Serotonin-norepinephrine reuptake inhibitors Amines Duloxetine Eli Lilly and Company Thiophenes Neuropathic pain Antidepressant Paroxetine Committee for Medicinal Products for Human Use Chemistry Medicine Organic chemistry
152	19 July 2012 EMA[removed]Committee for Medicinal Products for Human Use (CHMP) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:37:27 Health Pharmacy Clinical research European Medicines Agency Committee for Medicinal Products for Human Use Pharmacovigilance Norfloxacin Pharmaceutical sciences Drug safety Pharmacology
153	tygacil renewal q-and-a FINAL Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:11:14 Bacterial diseases Amides Tigecycline Staphylococcaceae Infectious diseases European Medicines Agency Peptostreptococcus Committee for Medicinal Products for Human Use Staphylococcus aureus Bacteria Microbiology Biology
154	Q&A on Withdrawal of the Marketing Application for Ximelagatran AtraZenica 36mg film coated tablets Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 05:57:39 Medicine Prodrugs Ximelagatran Warfarin European Medicines Agency Anticoagulant Oxazepam Committee for Medicinal Products for Human Use Chemistry AstraZeneca Pharmacology
155	13 February 2012 EMA/CHMP[removed]rev1 EMEA/H/A[removed] Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:23:42 Health Research Nimesulide Committee for Medicinal Products for Human Use European Medicines Agency Pharmacology
156	Recommendation to restrict the use of Protelos/Osseor (strontium ranelate) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:41:49 Drugs Osteopathies Osteoporosis Strontium ranelate European Medicines Agency Cardiovascular disease Myocardial infarction Committee for Medicinal Products for Human Use Norfloxacin Health Aging-associated diseases Medicine
157	Angiotensin Art[removed]Press release Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:22:51 Tetrazoles Carboxylic acids Benzimidazoles Benzoic acids Antihypertensive drug Valsartan European Medicines Agency Committee for Medicinal Products for Human Use Telmisartan Chemistry Organic chemistry Angiotensin II receptor antagonists
158	27 June 2013 EMA[removed]Committee for Medicinal Products for Human Use (CHMP) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:43:13 Pharmacology Angiology Clinical research European Medicines Agency Pharmaceutical industry Pharmacovigilance Committee for Medicinal Products for Human Use Summary of Product Characteristics Angiogenesis Medicine Pharmaceutical sciences Health
159	20 January 2011 EMA[removed]Committee for medicinal products for human use (CHMP) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:10:15 Medicine Immunosuppressants Neurological disorders Anatomy Diols Fingolimod Treatment of multiple sclerosis European Medicines Agency Sphingosine-1-phosphate Multiple sclerosis Autoimmune diseases Health
160	Benlysta - Summary of Opinion Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-07-21 06:15:00 Health Belimumab Systemic lupus erythematosus B-cell activating factor European Medicines Agency Committee for Medicinal Products for Human Use Autoantibody Anatomy Autoimmune diseases Monoclonal antibodies

UPDATE